Interim report
Page 1
Aster DM Quality Care Limited (Formerly Aster DM Healthcare Limited) Registered Office: No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038 Corporate Office: Brigade Deccan Heights 20th & 12th Floor, #42, 5th Mile, Tumkur Rd, Yeshwanthpur Industrial Area, Phase 1, Yeshwanthpur, Bengaluru-560022 CIN: L85110TS2008PLC207383 Telephone: +91 96060 61833 E-mail: cs@asterqualitycare.com Website: www.asterqualitycare.com 5 August 2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai 400001, Maharashtra, India Scrip Code: 540975 The National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai 400051, Maharashtra, India Scrip Symbol: ASTERDM Dear Sir/Madam, Subject: 1. Outcome of the Board Meeting - Unaudited Financial Results (standalone and consolidated) for the first quarter ended 30 June 2026 Ref: Regulation 30 and 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) With reference to our letter dated 30 July 2026 and in accordance with Regulation 30 and 33 of the Listing Regulations, we wish to inform you that the Board of Directors of Aster DM Quality Care Limited (formerly known as Aster DM Healthcare Limited) (“the Board” and “the Company”, respectively) at its meeting held today i.e. 5 August 2026, inter alia, has approved the unaudited financial results (standalone and consolidated) of the Company for the quarter ended 30 June 2026 (“UFRs”), as reviewed and recommended by the Audit Committee. A copy of UFRs, along with the limited review report thereon issued by M/s. Deloitte Haskins & Sells, Statutory Auditors are enclosed. The UFRs shall be published in the newspapers as required under the Listing Regulations. The Meeting of the Board of Directors commenced at 11:30 AM (IST) and concluded at 04:40 PM (IST). The above information will also be hosted on the website of the Company i.e. www.asterqualitycare.com This is for your information and records. Thanking you, For Aster DM Quality Care Limited (Formerly known as Aster DM Healthcare Limited) __________________ Hemish Purushottam Company Secretary and Compliance Officer M. No. A24331
Page 2
Chartered AccountantsPrestige Trade Tower, Level 1946, Palace Road, High Grounds Bengaluru 560 001Karnataka, IndiaTel: +91 80 6188 6000Fax: +91 80 6188 6011UNAUDITED STANDALONE FINANCIAL RESULTSTO THE BOARD OF DIRECTORS OF ASTER DM QUALITY CARE LIMITED (formerly known as ASTER DM HEALTHCARE LIMITED)1. We have reviewed the accompanying Statement of Unaudited Standalone Financial Results of ASTER DM QUALITY CARE LIMITED (formerly known as ASTER DM HEALTHCARE LIMITED)interim financial ) for the quarter ended 30 June 2026pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.2.the recognition and measurement principles laid down in the Indian Accounting of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review.3. We conducted our review of the Statement in accordance with the Standard on Review India (ICAI). A review of interim financial information consists of making inquiries, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33(8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, to the extent applicable.4. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the ListingsRegulations, including the manner in which it is to be disclosed, or that it contains any material misstatement.
Page 3
Page 2 of 2 5. The Unaudited Standalone Financial Results includes the interim financial information of the ESOP trust which have not been reviewed by its auditor whose interim financial information reflect total revenue of INR 0.56 crores, total net profit after tax of INR 0.42 crores and total comprehensive income of INR 0.42 crores for the quarter ended 30 June 2026, as considered in the Statement. According to the information and explanations given to us by the Management, these interim financial information are not material to the Company. Our conclusion on the Statement is not modified in respect of our reliance on the interim financial information certified by the Management. For Deloitte Haskins & Sells Chartered Accountants 008072S) Ankit Daga (Partner) (Membership No. 512486) (UDIN: 26512486AFXMIV2992) Place: Bengaluru Date: 5 August 2026
Page 4
(Amount in INR crores)Year ended30 June 2026 31 March 2026(refer Note 9)30 June 2025 31 March 2026(Audited)1 IncomeRevenue from operations 725.73 655.10 613.04 2,615.70 Other income 39.03 40.55 38.43 155.03 Total income 764.76 695.65 651.47 2,770.73 2 ExpensesPurchase of medicines and medical consumables 162.04 122.14 130.46 530.68 Changes in inventories (12.28) 8.15 (0.56) 8.49 Professional fees to consultant doctors 165.48 149.99 136.22 579.85 Laboratory outsourcing charges 21.91 18.98 17.92 78.55 Employee benefits expense 121.39 103.94 91.48 403.45 Finance costs 24.02 20.98 21.64 87.27 Depreciation and amortisation expenses 41.32 37.57 37.88 154.02 Other expenses 120.20 113.53 104.01 464.30 644.08 575.28 539.05 2,306.61 3 Profit before exceptional items and tax (1-2) 120.68 120.37 112.42 464.12 4 Exceptional items (refer Note 7)(109.79) (77.73) (4.39) (89.92) 5 Profit before tax (3+4) 10.89 42.64 108.03 374.20 6 Tax expensesCurrent tax 35.12 19.93 28.87 124.37 Deferred tax (9.93) (4.75) (1.43) (17.99) Total tax expense 25.19 15.18 27.44 106.38 7 Profit/(Loss) for the period / year (5-6) (14.30) 27.46 80.59 267.82 8 - 1.18 - (0.21)- (0.30) - 0.05 Other comprehensive income/(loss), net of taxes - 0.88 - (0.16) 9 Total comprehensive income/(loss) (7+8) (14.30) 28.34 80.59 267.66 10518.13 518.13 518.13 518.13 11 3,848.09 12Earnings/(Loss) per share (Face value of INR 10 each) Not annualised Not annualised Not annualised AnnualisedBasic (in INR) (0.28) 0.53 1.58 5.20 Diluted (in INR) (0.28) 0.53 1.57 5.19 See accompanying notes to the Statement of Unaudited Standalone Financial Results ParticularsQuarter endedRegistered office : No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038Aster DM Quality Care Limited(Formerly known as Aster DM Healthcare Limited)CIN : L85110TS2008PLC207383Statement of Unaudited Standalone Financial Results for the quarter ended 30 June 2026(Unaudited) Paid-up equity share capital (Face value of INR 10 each)Other equityTotal expensesOther comprehensive income/(loss) for the period / yearItems that will not be reclassified subsequently toprofitor lossRemeasurement of net defined benefit liabilityIncome tax relating to items that will not be reclassifiedto profit or loss
Page 5
Notes to the Statement of Unaudited Standalone Financial Results:1)2)3)4)5)6)7)8)9)10) For and on behalf of the Board of Directors of Aster DM Quality Care Limited CIN : L85110TS2008PLC207383Varun KhannaManaging Director & Group Chief Executive OfficerDIN 03584124Bengaluru05 August 2026 Aster DM Quality Care LimitedCIN : L85110TS2008PLC207383 Statement of Unaudited Standalone Financial Results are available for perusal at the website of the Company and the stock exchanges.In accordance with Ind AS 108, Operating Segments, segment information has been provided in the Statement of UnauditedConsolidatedFinancial Results of the Company and therefore no separate disclosure on segment information is given in the Statement ofUnauditedStandalone Financial Results.The figures for the quarter ended 31 March 2026 are balancing figures between the audited figures in respect of year ended 31 March2026and the unaudited published figures in respect of nine months ended 31 December 2025, which was subjected to limited review bythestatutory auditors. On 11 December 2025, the Company had submitted the Scheme of Amalgamation ('Scheme') by way of merger of Quality CareIndiaLimited (Transferor Company/QCIL) with Aster DM Healthcare Limited (Transferee Company) (the 'Applicant Companies') totheNational Company Law Tribunal ('NCLT') for approval of the said Scheme. Subsequently, on 19 June 2026, the NCLT has sanctionedtheScheme. On 26 June 2026, the Applicant Companies filed e-Form INC-28 with the Registrar of Companies, Telangana. Upon suchfilingand completion of all other conditions precedent as mentioned in the Scheme, the Scheme became effective on 01 July 2026, being thefirstday of the calendar month immediately following the month in which all such conditions are fulfilled. As per the terms of the Scheme,thename of the Company has been changed from "Aster DM Healthcare Limited" to "Aster DM Quality Care Limited".During the quarter ended 30 June 2026, the Company has incurred expenses amounting to INR 109.79 crores towards professional feesandsuch other costs relating to the merger. The same has been presented as Exceptional Items in the Statement. (Formerly known as Aster DM Healthcare Limited) On 18 June 2026, the Company has made an additional investment in equity shares amounting to INR 45.09 Crores in AsterDM-SuperSpecialty Hospital (Sarjapur) Private Limited, a wholly owned subsidiary of the Company.On 29 June 2026, the Company has made an additional investment in Optionally Convertible Redeemable Preference Shares(OCRPS)amounting to INR 25.00 crores in Alfaone Medicals Private Limited, an associate of the Company. Registered office : No 7-1-450/20, Plot No-04, Mythri Vihar, Sanjeev Reddy Nagar, Ameerpet, Hyderabad, Telangana, India, 500038The Statement of Unaudited Standalone Financial Results of Aster DM Quality Care Limited ('the Company'), which includes thefinancialinformation of DM Healthcare Employees Welfare Trust (the 'ESOP Trust'), for the quarter ended 30 June 2026 ('the Statement') hasbeenreviewed by the Audit Committee and approved by the Board of Directors on 05 August 2026. The Statement has been subjected tolimitedreview by Deloitte Haskins & Sells, the statutory auditor of the Company, who have expressed an unmodified review conclusion.The Statement has been prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 'InterimFinancialReporting, prescribed under Section 133 of the Companies Act, 2013 read with the relevant rules thereunder and in terms of SEBI(ListingObligations and Disclosure Requirements) Regulations, 2015, as amended from time to time.The Company acquired additional 1.54% stake in its subsidiary Malabar Institute of Medical Sciences Limited, from severalminorityshareholders during the period 1 April 2026 to 30 June 2026 for an amount of INR 31.40 crores. Consequent to the saidacquisition,shareholding of the Company in Malabar Institute of Medical Sciences Limited has increased from 79.75% as at 31 March 2026 to 81.29%as at 30 June 2026.
Page 6
Page 1 of 4 Chartered AccountantsPrestige Trade Tower, Level 1946, Palace Road, High Grounds Bengaluru 560 001Karnataka, IndiaTel: +91 80 6188 6000Fax: +91 80 6188 6011 UNAUDITED CONSOLIDATED FINANCIAL RESULTSTO THE BOARD OF DIRECTORS OF ASTER DM QUALITY CARE LIMITED (formerly known as ASTER DM HEALTHCARE LIMITED)1. We have reviewed the accompanying Statement of Unaudited Consolidated Financial Results of ASTER DM QUALITY CARE LIMITED (formerly known as ASTER DM HEALTHCARE LIMITED) tax and total comprehensive loss of its associates for the quarter ended 30 June 2026 ncludes the financial information of DM Healthcare Employees requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure 2.recognition and measurement principles laid down in the Indian Accounting Standard Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review.3. We conducted our review of the Statement in accordance with the Standard on Review ,issued by the Institute of Chartered Accountants of India (ICAI). A review of interim financial information consists of making inquiries, applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under Section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33(8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, to the extent applicable.4. The Statement includes the results of the entities as provided in Annexure 1.5. Based on our review conducted and procedures performed as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of the Listing Regulations including the manner in which it is to be disclosed, or that it contains any material misstatement.
Page 7
Page 2 of 4 6. The Unaudited Consolidated Financial Results includes the interim financial information of 16 subsidiaries and ESOP trust which have not been reviewed by their auditors, whose interim financial information reflect total revenue of INR 61.53 crores, total loss after tax of INR 4.41 crores and total comprehensive loss of INR 4.41 crores for the quarter ended 30 June 2026, as considered in the Statement. The Unaudited Consolidated Financial Results also include the Group's share of net profit after tax of INR 0.15 crores and total comprehensive income of INR 0.15 crores for the quarter ended 30 June 2026, as considered in the Statement, in respect of 2 associates based on their interim financial information which have not been reviewed by their auditors. According to the information and explanations given to us by the Management, these interim financial information are not material to the Group. Our Conclusion on the Statement is not modified in respect of our reliance on the interim financial information certified by the Management. For Deloitte Haskins & Sells Chartered Accountants 008072S) Ankit Daga Partner (Membership No. 512486) (UDIN:26512486CGUGXM8845) Place: Bengaluru Date: 5 August 2026
Page 8
Page 3 of 4 Annexure 1 List of entities included in the Unaudited Consolidated Financial Results
Page 9
Page 4 of 4